Terms: = Breast cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b AND Prognosis
28 results:
1. Copper homeostasis-associated gene PRNP regulates ferroptosis and immune infiltration in breast cancer.
Lin C; He J; Tong X; Song L
PLoS One; 2023; 18(8):e0288091. PubMed ID: 37535656
[TBL] [Abstract] [Full Text] [Related]
2. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
[TBL] [Abstract] [Full Text] [Related]
4. LINC00958: A promising long non-coding RNA related to cancer.
Li H; Gao J; Liu L; Zhang S
Biomed Pharmacother; 2022 Jul; 151():113087. PubMed ID: 35569349
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract] [Full Text] [Related]
6. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
[TBL] [Abstract] [Full Text] [Related]
7. HER2 testing across practices-Have we come to a consensus on the ideal method of testing? A systematic literature review.
Nassar A; Pooja A; Chivukula M
Breast J; 2020 Jun; 26(6):1185-1188. PubMed ID: 32400119
[TBL] [Abstract] [Full Text] [Related]
8. Quantitative Histopathology of Stained Tissues using Color Spatial Light Interference Microscopy (cSLIM).
Majeed H; Keikhosravi A; Kandel ME; Nguyen TH; Liu Y; Kajdacsy-Balla A; Tangella K; Eliceiri KW; Popescu G
Sci Rep; 2019 Oct; 9(1):14679. PubMed ID: 31604963
[TBL] [Abstract] [Full Text] [Related]
9. Collagen organization of renal cell carcinoma differs between low and high grade tumors.
Best SL; Liu Y; Keikhosravi A; Drifka CR; Woo KM; Mehta GS; Altwegg M; Thimm TN; Houlihan M; Bredfeldt JS; Abel EJ; Huang W; Eliceiri KW
BMC Cancer; 2019 May; 19(1):490. PubMed ID: 31122202
[TBL] [Abstract] [Full Text] [Related]
10. Radiogenomics: bridging imaging and genomics.
Bodalal Z; Trebeschi S; Nguyen-Kim TDL; Schats W; Beets-Tan R
Abdom Radiol (NY); 2019 Jun; 44(6):1960-1984. PubMed ID: 31049614
[TBL] [Abstract] [Full Text] [Related]
11. Ex Vivo Detection of Circulating Tumor Cells from Whole Blood by Direct Nanoparticle Visualization.
Sobral-Filho RG; DeVorkin L; Macpherson S; Jirasek A; Lum JJ; Brolo AG
ACS Nano; 2018 Feb; 12(2):1902-1909. PubMed ID: 29401387
[TBL] [Abstract] [Full Text] [Related]
12. Bioconjugated fluorescent organic nanoparticles targeting EGFR-overexpressing cancer cells.
Faucon A; Benhelli-Mokrani H; Fleury F; Dutertre S; Tramier M; Boucard J; Lartigue L; Nedellec S; Hulin P; Ishow E
Nanoscale; 2017 Nov; 9(45):18094-18106. PubMed ID: 29135000
[TBL] [Abstract] [Full Text] [Related]
13. Targeting metastasis-initiating cells through the fatty acid receptor CD36.
Pascual G; Avgustinova A; Mejetta S; Martín M; Castellanos A; Attolini CS; Berenguer A; Prats N; Toll A; Hueto JA; Bescós C; Di Croce L; Benitah SA
Nature; 2017 Jan; 541(7635):41-45. PubMed ID: 27974793
[TBL] [Abstract] [Full Text] [Related]
14. MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy.
Calhoun BC; Portier B; Wang Z; Minca EC; Budd GT; Lanigan C; Tubbs RR; Morrison LE
BMC Cancer; 2016 Aug; 16(1):695. PubMed ID: 27576528
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of Paired Primary-Metastatic Hormone-Receptor Positive breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance.
Manso L; Mourón S; Tress M; Gómez-López G; Morente M; Ciruelos E; Rubio-Camarillo M; Rodriguez-Peralto JL; Pujana MA; Pisano DG; Quintela-Fandino M
PLoS One; 2016; 11(5):e0155840. PubMed ID: 27195705
[TBL] [Abstract] [Full Text] [Related]
16. Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer.
Xiang QM; Wang LW; Yuan JP; Chen JM; Yang F; Li Y
Exp Mol Pathol; 2015 Aug; 99(1):133-8. PubMed ID: 26102249
[TBL] [Abstract] [Full Text] [Related]
17. Telomere length alterations unique to invasive lobular carcinoma.
Heaphy CM; Asch-Kendrick R; Argani P; Meeker AK; Cimino-Mathews A
Hum Pathol; 2015 Aug; 46(8):1197-203. PubMed ID: 26092192
[TBL] [Abstract] [Full Text] [Related]
18. Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplification.
Varga Z; Tubbs RR; Moch H
PLoS One; 2014; 9(8):e105961. PubMed ID: 25153153
[TBL] [Abstract] [Full Text] [Related]
19. Segmentation for the enhancement of microcalcifications in digital mammograms.
Milosevic M; Jankovic D; Peulic A
Technol Health Care; 2014; 22(5):701-15. PubMed ID: 25059254
[TBL] [Abstract] [Full Text] [Related]
20. Coculture system with an organotypic brain slice and 3D spheroid of carcinoma cells.
Chuang HN; Lohaus R; Hanisch UK; Binder C; Dehghani F; Pukrop T
J Vis Exp; 2013 Oct; (80):. PubMed ID: 24145580
[TBL] [Abstract] [Full Text] [Related]
[Next]